Medetomidine hapten, monoclonal antibody, hybridoma cell strain and application thereof
By synthesizing metoprimidine hapten and complete antigen, a highly sensitive hybridoma cell line was prepared, solving the problems of expensive equipment and complex sample purification in existing metoprimidine detection technologies, and realizing a rapid and simple detection method.
Patent Information
- Application Number
- CN202511417785.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-30
- Publication Date
- 2026-01-16
AI Technical Summary
Existing methods for detecting tomididine in the United States require thorough sample purification, consume a lot of solvent, and have expensive equipment. They lack rapid and simple detection methods and also lack monoclonal antibodies with high specificity and sensitivity.
By synthesizing the medetomidine hapten, the medetomidine complete antigen was prepared. Hybridoma cell lines secreting medetomidine monoclonal antibodies were obtained by immunizing mice. High-sensitivity hybridoma cell lines were screened and applied to enzyme-linked immunosorbent assay (ELISA) detection.
A highly sensitive and specific medemidin monoclonal antibody was obtained, which can be effectively applied to rapid and convenient medemidin detection, suitable for on-site testing of large numbers of samples, and reduces testing costs.
Smart Images

Figure CN121343922A_ABST
Abstract
Citation Information
Cited By
Metomidine haptens and complete antigens, and methods of making and using the same
CN122355942A